Current Oncology Reports

Article	Citations
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?	163
Clinical and Biological Features of Neuroendocrine Prostate Cancer	139
Update on Osteosarcoma	114
Update on Management of Squamous Cell Esophageal Cancer	98
Targeting Apoptosis in Cancer	90
Cardiotoxicity of Immune Checkpoint Inhibitors	65
Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers	61
Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors	61
Immunotherapy for Non-melanoma Skin Cancer	60
Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment	56
WEE1 Inhibitor: Clinical Development	52
Immunotherapy in Cervical Cancer	52
Bystander effect of antibody–drug conjugates: fact or fiction?	50
Ependymoma: Evaluation and Management Updates	48
CAR-T Therapies in Solid Tumors: Opportunities and Challenges	47
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors	41
Giant Cell Tumor of Bone: An Update	41
Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy	40
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications	39
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)	39
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies	37
Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality	37
Disparities in Lung Cancer Treatment	33
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities	33
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics	33

The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy	31
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer	30
Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a System	30
ROS1 Targeted Therapies: Current Status	30
Targeting KRAS in Colorectal Cancer	29
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation	29
Fatty Acid Metabolism and Cancer Immunotherapy	28
COVID and Lung Cancer	28
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors	27
Prostate Cancer Immunotherapy—Finally in From the Cold?	27
Current Advances in Immunotherapy for Glioblastoma	27
The Treatment Landscape of Advanced Hepatocellular Carcinoma	26
Engineered T Cells: CAR T Cell Therapy and Beyond	26
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors	26
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma	25
Cancer Pain Management—New Therapies	24
Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment	24
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer	23
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs	23
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer	22
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management	22
Global Perceptions of Women on Breast Cancer and Barriers to Screening	21
Management of the Neck in Well-Differentiated Thyroid Cancer	21
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib	21
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment	21
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?	21
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?	20
Rare Breast Cancer Subtypes	20
Chemotherapy in Cutaneous Melanoma: Is There Still a Role?	20
Global Perspectives on Palliative Care for Cancer Patients: Not All Countries Are the Same	20
Richter Syndrome	20
Cytokines in the Treatment of Melanoma	19
Desmoid Fibromatosis: Management in an Era of Increasing Options	19
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes	19
CAR T-Cell Therapy in the Older Person: Indications and Risks	19
IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions	19
Chemotherapy and Radiation-Associated Cardiac Autonomic Dysfunction	18
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy	18
Role of Platinums in Triple-Negative Breast Cancer	18
Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base	18
COVID-19 in Children with Cancer	17
Role of Machine Learning and Artificial Intelligence in Interventional Oncology	17
Current Clinical Trial Landscape of OX40 Agonists	17
Neuroendocrine Tumors: a Relevant Clinical Update	17
Palliative Care in Paediatric Oncology: an Update	17
Updates in Cardiac Amyloidosis Diagnosis and Treatment	17
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review	17
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature	17
Lymphoblastic Lymphoma: a Concise Review	16
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?	16

DNA Repair Mechanisms and Therapeutic Targets in Glioma	16
Radiogenomics in Interventional Oncology	16
Updates on Surgical Management and Advances for Brain Tumors	16
Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?	16
Immune Checkpoint Inhibitors and Novel Immunotherapy Approaches for Breast Cancer	16
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?	16
Oncolytic Viruses and Cancer Immunotherapy	16
Immunology of Lynch Syndrome	16
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities	16
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment	16
Progress Update in Pediatric Renal Tumors	16
Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy	15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment	15
Management of Upper Tract Urothelial Carcinoma	15
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer	15
Palliative and End-of-Life Care for Sexual and Gender Minority Cancer Survivors: a Review of Current Research and Recommendations	15
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia	15
Approaches to Non-Muscle-Invasive Bladder Cancer	15
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice	15
Acute Leukemia in Infants	14
Circulating Tumour DNA in Melanoma—Clinic Ready?	14
Evolving Treatment Approaches to Mucosal Melanoma	14
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients	14
The Role and Impact of Minimal Residual Disease in NSCLC	14
Induction Chemotherapy for Advanced Oral Cavity Cancer	14
A New Generation of Vaccines in the Age of Immunotherapy	14
Radiotherapy and Immunotherapy Combinations for Lung Cancer	14
Current Role of Functional Imaging in the Management of Lymphoma	14
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology	14
Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis	14
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology	14
Mitochondrial Inhibition: a Treatment Strategy in Cancer?	14
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer	14
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?	14
Treatment of Recurrent or Metastatic Adenoid Cystic Carcinoma	13
Childhood Acute Leukemias in Developing Nations: Successes and Challenges	13
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building	13
AXL Inhibitors: Status of Clinical Development	13
Cardiovascular Risks with Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors and Monoclonal Antibody Therapy	13
An Update on FLT3 in Acute Myeloid Leukemia: Pathophysiology and Therapeutic Landscape	13
Improving Breast Cancer Responses to Immunotherapy—a Search for the Achilles Heel of the Tumor Microenvironment	13
Cardiovascular Toxicities of CAR T-cell Therapy	13
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic	13
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications	13
Recent Progress in Mind–Body Therapies in Cancer Care	13
New Directions in Treatment of Metastatic or Advanced Pheochromocytomas and Sympathetic Paragangliomas: an American, Contemporary, Pragmatic Approach	13
Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy	12
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?	12
Immunotherapy in Head and Neck Cancer: Where Do We Stand?	12
Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies	12
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner	12
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy	12
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	12
Vitamin D in Head and Neck Cancer: a Systematic Review	12
Microtubule Inhibitors and Cardiotoxicity	12
Alternative Checkpoints as Targets for Immunotherapy	12
Prostate-Specific Membrane Antigen (PSMA)-Targeted Radionuclide Therapies for Prostate Cancer	12
Cancer Prehabilitation in Practice: the Current Evidence	11
Neutropenia and Infection Prophylaxis in Childhood Cancer	11
The Concept of Respite in Palliative Care: Definitions and Discussions	11
The Latest Option: Nivolumab and Relatlimab in Advanced Melanoma	11
Antibiotic Management of Patients with Hematologic Malignancies: From Prophylaxis to Unusual Infections	11
Percutaneous Management of Breast Cancer: a Systematic Review	11
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	11
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy	11
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?	10
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis	10
New Developments in Gastric Neuroendocrine Neoplasms	10
Approaches to First-Line Therapy for Metastatic Clear Cell Renal Cell Carcinoma	10
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis	10
New Treatments for Recurrent Uterine Cancer	10
Advances in the Management of Pediatric Sarcomas	10
Challenges of Survivorship for Older Adults Diagnosed with Cancer	10
Do Cancer and Cancer Treatments Accelerate Aging?	10
Fertility-Sparing and Less Radical Surgery for Cervical Cancer	10
Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy	10
Medicinal Mushroom Supplements in Cancer: A Systematic Review of Clinical Studies	10
Mitochondrial Dynamin-Related Protein Drp1: a New Player in Cardio-oncology	10
Recent Advances and Applications of Radiation Therapy for Brain Metastases	10
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer	10

Diagnosis and Management of Stroke in Adults with Primary Brain Tumor	10
Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer	9
Interdisciplinary Approaches to Survivorship with a Focus on the Low-grade and Benign Brain Tumor Populations	9
3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?	9
Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All?	9
Resistance to Poly (ADP-Ribose) Polymerase Inhibitors (PARPi): Mechanisms and Potential to Reverse	9
Discussing Prognosis with Empathy to Cancer Patients	9
Liver-Directed Therapies for Neuroendocrine Neoplasms	9
Belzutifan (MK-6482): Biology and Clinical Development in Solid Tumors	9
Viral and Clinical Oncology of Head and Neck Cancers	9
New Insights on Tramadol and Immunomodulation	9
Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission	9
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities	9
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients	9
Surgical Management of Melanoma: Advances and Updates	9
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	9
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions	8
Role of Body Composition in the Prediction of Skeletal Fragility Induced by Hormone Deprivation Therapies in Cancer Patients	8
Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022	8
Treatment of Metastatic Melanoma in the Elderly	8
Hairy Cell Leukemia: Where Are We in 2023?	8
Tumor and Systemic Immunomodulatory Effects of MEK Inhibition	8
Recent Advances in Melanoma Diagnosis and Prognosis Using Machine Learning Methods	8
Global Longitudinal Strain Monitoring to Guide Cardioprotective Medications During Anthracycline Treatment	8
Easing the Journey—an Updated Review of Palliative Care for the Patient with High-Grade Glioma	8
Erythroleukemia: an Update	8
Chemokine Receptor Antagonists: Role in Oncology	8
Anti-PD-1: When to Stop Treatment	8
Managing the Risk of Infection in Chronic Lymphocytic Leukemia in the Era of New Therapies	8
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy	8
The Microbiome’s Influence on Head and Neck Cancers	8
Intratumoral Immunotherapy: Is It Ready for Prime Time?	8
Predictors of Nodal Metastasis in Cutaneous Head and Neck Cancers	8
Interventions to Reduce Sedentary Behavior in Cancer Patients and Survivors: a Systematic Review	8
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes	8
Breast Cancer Survivorship: the Role of Rehabilitation According to the International Classification of Functioning Disability and Health—a Scoping Review	8
New Tyrosine Kinase Inhibitors for the Treatment of Gastrointestinal Stromal Tumors	8
The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic	8
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment	8
The Emerging Role of Next-Generation Imaging in Prostate Cancer	8
Influence of Perioperative Anesthesia on Cancer Recurrence: from Basic Science to Clinical Practice	8
Large Granular Lymphocytic Leukemia: Current State of Diagnosis, Pathogenesis and Treatment	7
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review	7
The Symptom Experience in Pediatric Cancer: Current Conceptualizations and Future Directions	7
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer	7
The Role of Radiation Therapy in the Older Patient	7
Extracellular vesicles and their associated miRNAs as potential prognostic biomarkers in chronic lymphocytic leukemia	7
Dealing with Family Conflicts in Decision-making in End-of-Life Care of Advanced Cancer Patients	7
Diagnostic and Therapeutic Updates in Leptomeningeal Disease	7
Emerging Studies of Melanoma Brain Metastasis	7
Cancer Immunotherapies: What the Perioperative Physician Needs to Know	7
Oncology During the COVID-19 Pandemic: a Lockdown Perspective	7
Tumor Biomarkers and Interventional Oncology: Impact on Local Outcomes for Liver and Lung Malignancy	7
Emerging Role of Biomarkers in Testicular Germ Cell Tumors	7
Quality of Life and Survivorship in Lymphoma	7
Richter’s Transformation	7
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group	7
Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review	7
Persistent and Chronic Perioperative Pain After Cancer Surgery	7
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges	7
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	7
Carcinoid Heart Disease: a Review	7
Newly Diagnosed Glioblastoma in Elderly Patients	7
Treatment Following Progression in Metastatic Melanoma: the State of the Art from Scientific Literature to Clinical Need	6
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions	6
Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock	6
Chemotherapy Duration for Various Indications in Colorectal Cancer: a Review	6
Mucosal Melanoma: Epidemiology, Clinical Features, and Treatment	6
Acupuncture for Cancer-Related Anorexia: a Review of the Current Evidence	6
Is Myelodysplasia a Consequence of Normal Aging?	6
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?	6
Assessment of Cancer-Associated Cachexia — How to Approach Physical Function Evaluation	6
How to Measure Pain	6
New Directions in Imaging Neuroendocrine Neoplasms	6
Update on Histological Reporting Changes in Neuroendocrine Neoplasms	6
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer	6
The Presence of Complementary and Alternative Medicine Recommendations in Head and Neck Cancer Guidelines: Systematic Review and Quality Assessment	6
Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma	6
Current Approaches to Philadelphia Chromosome–Positive B-Cell Lineage Acute Lymphoblastic Leukemia: Role of Tyrosine Kinase Inhibitor and Stem Cell Transplant	6
Hormone-Dependent Tumors and Sexuality in the Neuro-Oncology of Women (N.O.W.): Women’s Brain Tumors, Gaps in Sexuality Considerations, and a Need for Evidence-Based Guidelines	6
Advances in Molecular Profiling and Developing Clinical Trials of CNS Germ Cell Tumors: Present and Future Directions	6
Active Surveillance of Thyroid Microcarcinomas: a Critical View	6
Chronic Myelogenous Leukemia in Childhood	6
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	6
Targeting the mu-Opioid Receptor for Cancer Treatment	6
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?	5
Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma	5
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development	5
Management of Clinically Regional Node-Positive Urothelial Carcinoma of the Bladder	5
An Overview of Angiogenesis in Bladder Cancer	5
Emerging Therapies for Transthyretin Amyloidosis	5
Cardiovascular Impact of Androgen Deprivation Therapy: from Basic Biology to Clinical Practice	5
A Systematic Review and Quality Assessment of Breast Cancer Clinical Practice Guidelines Providing Complementary and Alternative Medicine Recommendations	5
Immune Checkpoint Inhibitors in the Aged	5
First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly	5